icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
rTZQ5Y57zn0KgLUw
Listen
